Sarepta Therapeutics · 1 day ago
Biostatistics Intern
Maximize your interview chances
BiotechnologyGenetics
Growth OpportunitiesNo H1B
Insider Connection @Sarepta Therapeutics
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
The intern will be responsible for developing understanding of the company’s data on key efficacy measurements, perform analysis of repeated measures data and time to event data.
The intern will perform statistical simulations in SAS, R, Python to assess different statistical methods/models and their performance.
Perform ad-hoc and exploratory statistical analyses as needed.
Support and contribute to the preparation of publications, including manuscripts, posters, and oral presentations.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
MS or equivalent in statistics, biostatistics or related field, preferably a PhD candidate
Proficiency in statistical methods, including generalized linear mixed models, survival analysis.
Ability to handle large data in SAS and R and perform statistical simulations
Excellent communication and presentation skills, including the ability to effectively communicate statistical and data science concepts in a clear and concise manner to non-technical audience.
Good organizational skills, sufficient to multi-task in a fast-paced environment with changing priorities.
Team player, with ability to collaborate successfully across functions.
Candidates must be legally allowed and available to work full-time for up to 12 weeks in the summer of 2025
Candidates must be authorized to work in the U.S.
Preferred
Knowledge and hands-on experience with causal inference, machine learning, artificial intelligence (e.g., General Adversarial Networks, Transformers, Bayesian Networks), survival analysis, propensity score methods, external control comparison, Bayesian methods desirable
Company
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.39BKey Investors
Michael Andrew ChambersPharmakon AdvisorsMidCap Financial
2022-09-14Post Ipo Equity· $5.96M
2021-10-13Post Ipo Equity· $500M
2020-02-14Post Ipo Equity· $400M
Recent News
2024-12-21
2024-12-20
Company data provided by crunchbase